SERPINF1 and neoplasm: To sum up, PEDF-treated cells show changes in cytoplasm size, decreased cell cycle kinetics, increased drug resistance, and the capacity to produce tumors with not only a lower growth rate but also lower tumor volume and fewer necrotic areas.